Activated RET and ROS: two new driver mutations in lung adenocarcinoma

由 Bos, Marc, Gardizi, Masyar, Schildhaus, Hans-Ulrich, Buettner, Reinhard, Wolf, Juergen
發表在 Transl Lung Cancer Res (2013)

Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology

由 Alidousty, Christina, Baar, Till, Heydt, Carina, Wagener-Ryczek, Svenja, Kron, Anna, Wolf, Juergen, Buettner, Reinhard, Schultheis, Anne Maria
發表在 J Thorac Dis (2019)

Foetal age determination and development in elephants

由 Hildebrandt, Thomas, Drews, Barbara, Gaeth, Ann P, Goeritz, Frank, Hermes, Robert, Schmitt, Dennis, Gray, Charlie, Rich, Peter, Streich, Wolf Juergen, Short, Roger V, Renfree, Marilyn B
出版 2006

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES

由 Galldiks, Norbert, Abdulla, Diana, Scheffler, Matthias, Schweinsberg, Viola, Schlaak, Max, Kreuzberg, Nicole, Landsberg, Jenny, Lohmann, Philipp, Ceccon, Garry, Werner, Jan-Michael, Celik, Eren, Ruge, Maximilian, Kocher, Martin, Marnitz, Simone, Fink, Gereon, Langen, Karl-Josef, Wolf, Juergen, Mauch, Cornelia
發表在 Neurooncol Adv (2019)

PAN-CANCER EFFICACY OF VEMURAFENIB IN BRAF(V600)-MUTANT NON-MELANOMA CANCERS

由 Subbiah, Vivek, Puzanov, Igor, Blay, Jean-Yves, Chau, Ian, Lockhart, A. Craig, Raje, Noopur S., Wolf, Juergen, Baselga, Jose, Meric-Bernstam, Funda, Roszik, Jason, Diamond, Eli L., Riely, Gregory J., Sherman, Eric J., Riehl, Todd, Pitcher, Bethany, Hyman, David M.
發表在 Cancer Discov (2020)

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Cli...

由 Jänne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin, Vansteenkiste, Johan
發表在 JAMA (2017)

CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY

由 Heist, Rebecca S, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J M, Tan, Daniel S W, Hida, Toyoaki, de Jonge, Maja, V Orlov, Sergey, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Le Mouhaer, Sylvie, Robeva, Anna, Waldron-Lynch, Maeve, Giovannini, Monica, Wolf, Juergen
發表在 Neuro Oncol (2019)

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

由 Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
出版 2014

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

由 Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y., Goldwasser, Meredith, Boral, Anthony L., Engelman, Jeffrey A.
出版 2014

Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations

由 Pal, Sumanta K., Rosenberg, Jonathan E., Hoffman-Censits, Jean H., Berger, Raanan, Quinn, David I., Galsky, Matthew D., Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, Jan H. M., Gravis, Gwenaelle, Medioni, Jacques, Maroto, Pablo, Sriuranpong, Virote, Charoentum, Chaiyut, Burris, Howard A., Grünwald, Viktor, Petrylak, Daniel, Vaishampayan, Ulka, Gez, Eliahu, De Giorgi, Ugo, Lee, Jae-Lyun, Voortman, Jens, Gupta, Sumati, Sharma, Sunil, Mortazavi, Amir, Vaughn, David J., Isaacs, Randi, Parker, Katie, Chen, Xueying, Yu, Kun, Porter, Dale, Porta, Diana Graus, Bajorin, Dean F.
發表在 Cancer Discov (2018)

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

由 Gautschi, Oliver, Milia, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David P., Owen, Dwight, Camidge, Ross, Narayanan, Vignhesh, Doebele, Robert C., Besse, Benjamin, Remon-Masip, Jordi, Janne, Pasi A., Awad, Mark M., Peled, Nir, Byoung, Chul-Cho, Karp, Daniel D., Van Den Heuvel, Michael, Wakelee, Heather A., Neal, Joel W., Mok, Tony S.K., Yang, James C.H., Ou, Sai-Hong Ignatius, Pall, Georg, Froesch, Patrizia, Zalcman, Gérard, Gandara, David R., Riess, Jonathan W., Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Früh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha I., Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian, Mazières, Julien, Drilon, Alexander
發表在 J Clin Oncol (2017)